Visiongain has published a new report on Testosterone Replacement Therapy Market Report 2021-2031: Forecasts By Product (Oral, Parenteral, Implants, Gel/Creams, Patches, Buccal Adhesive, and Others), By Dosage Form (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries, and Others) By Drug Active Ingredient (Testosterone, Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Methyltestosterone, and Others), By Patient Demographics (Adults, Geriatric, and Pediatric), By End User (Hospital, Homecare, Specialty Clinics, and Others), By Distribution Channel (Direct Tender, and Retail Sales), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
COVID-19 Impact on Testosterone Replacement Therapy
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Testosterone Replacement Therapy. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analyzed herein the report are mentioned below:
Download Exclusive Sample of Report @ https://www.visiongain.com/report/testosterone-replacement-therapy-market-2021/#download_sampe_div
Market Drivers
Increasing Prevalence of Testosterone Deficiency
Testosterone deficiency prevalence has increased very rapidly, and it is expected that testosterone deficiency prevalence will increase during the forecast period. Increasing testosterone deficiency cases creates a huge demand for the testosterone deficiency treatment. Due to which Increasing prevalence of testosterone deficiency is working as a driver for the testosterone replacement therapy market.
Government initiative and awareness program
Governments and various other international organizations, regulatory authorities, independent authority, non-profit organizations are launching various awareness programs across the developed & developing countries to increase awareness regarding awareness for testosterone deficiency treatment. Increasing government initiative and awareness programs is expected to increase demand of testosterone replacement therapy and is working as a driver for the testosterone replacement therapy market.
Market Opportunities
Increasing focus on Healthcare Infrastructure and Advance Healthcare Facility
Healthcare infrastructure in developing nations is undergoing tumultuous changes from the last few years and each change is only for a better healthcare delivery, and to incorporate all the sections of the population. Increasing focus on healthcare infrastructure and advanced healthcare facilities is expected to increase public spending which is expected to create new opportunities for the testosterone replacement therapy market. Due to this reason the factor is creating various opportunities for the testosterone replacement therapy market.
Get Detailed TOC @ https://www.visiongain.com/report/testosterone-replacement-therapy-market-2021/#download_sampe_div
How the Testosterone Replacement Therapy Market report helps you
In summary, our 200+ page report provides you with the following knowledge:
- Revenue forecasts to 2031 for Testosterone Replacement Therapy Market, with forecasts for Get our report today Testosterone Replacement Therapy Market Forecast 2021-2031: By Product, By Dosage Form, Drug Active Ingredient, Patient Demographics, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Testosterone Replacement Therapy market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Testosterone Replacement Therapy Market.
Competitive Landscape
Top companies (AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., and Eli Lilly and Company) constitute more than XX% share of the global Testosterone Replacement Therapy. Other companies profiled in the report include Kyowa Kirin International plc, Mylan N.V., Novartis AG, Pfizer, Inc., Clarus Therapeutics and Allergan plc Some of the key developments are listed below:
In 2019, Lupin has received U.S. FDA approval for testosterone gel 1.62% for the treatment of hypogonadism as replacement therapy for men with. Testosterone gel 1.62% is the generic version AndroGel, 1.62% manufactured by AbbVie. The approval will help the company to expand its market portfolio.
Teva Pharmaceutical Industries Ltd. has launched AndroGeli (testosterone gel) a generic version. Testosterone Gel 1.62% CIII is used for treatment of primary hypogonadism (congenital or acquired), and hypogonadotropic hypogonadism (congenital or acquired) as a replacement therapy. The approval will help the company to increase its revenue generation.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
with our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Testosterone Replacement Therapy Market and leading companies. You will find data, trends, and predictions.
Find more Visiongain's research reports of Therapeutic Drugs Sector click on the following links:
- Cellular Immunotherapy Market
- Respiratory Drug Delivery Market
- Vaccine Drug Delivery Market
- Acute Kidney Injury Treatment Market
- Checkpoint Inhibitors for Treating Cancer Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Email: sara.peerun@visiongain.com
Web: https://www.visiongain.com/
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.